RARRES2 and metabolic dysfunction-associated steatotic liver disease: In addition, elevations in serum chemerin levels were found in patients with NAFLD and NASH compared to healthy controls [10] and have been shown to positively correlate with markers of liver pathology, including fibrosis, portal inflammation and NAFLD activity score (NAS) [11].